⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15514273 | 1.00 | — | — | |
| SCHEMBL15514272 | 1.00 | — | — | |
| SCHEMBL333964 | 0.73 | — | — | |
| SCHEMBL3053900 | 0.73 | — | — | |
| SCHEMBL3053897 | 0.73 | — | — | |
| SCHEMBL2323549 | 0.73 | — | — | |
| SCHEMBL333963 | 0.73 | — | — | |
| SCHEMBL2468283 | 0.71 | — | — | |
| SCHEMBL1220503 | 0.71 | — | — | |
| SCHEMBL2360242 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2867229-B1 | PYRROLIDINE DERIVATIVES AND THEIR USE AS COMPLEMENT PATHWAY MODULATORS | NOVARTIS AG (CH) | 2017-07-26 | — | — | EP | disclosed |
| EP-2867229-B1 | PYRROLIDINE DERIVATIVES AND THEIR USE AS COMPLEMENT PATHWAY MODULATORS | NOVARTIS AG (CH) | 2017-07-26 | — | — | EP | disclosed |
| US-9464081-B2 | Pyrrolidine derivatives and their use as complement pathway modulators | NOVARTIS AG (CH) | 2016-10-11 | — | — | US | disclosed |
| US-9464081-B2 | Pyrrolidine derivatives and their use as complement pathway modulators | NOVARTIS AG (CH) | 2016-10-11 | — | — | US | disclosed |
| US-9464081-B2 | Pyrrolidine derivatives and their use as complement pathway modulators | NOVARTIS AG (CH) | 2016-10-11 | — | — | US | disclosed |
| US-9368363-B2 | Etching gas and etching method | ZEON CORPORATION (JP) | 2016-06-14 | — | — | US | disclosed |
| US-20150322060-A1 | PYRROLIDINE DERIVATIVES AND THEIR USE AS COMPLEMENT PATHWAY MODULATORS | NOVARTIS AG (CH) | 2015-11-12 | — | — | US | disclosed |
| US-20150322060-A1 | PYRROLIDINE DERIVATIVES AND THEIR USE AS COMPLEMENT PATHWAY MODULATORS | NOVARTIS AG (CH) | 2015-11-12 | — | — | US | disclosed |
| US-20150322060-A1 | PYRROLIDINE DERIVATIVES AND THEIR USE AS COMPLEMENT PATHWAY MODULATORS | NOVARTIS AG (CH) | 2015-11-12 | — | — | US | disclosed |
| US-20140073139-A1 | ETCHING GAS AND ETCHING METHOD | ZEON CORPORATION (JP) | 2014-03-13 | — | — | US | disclosed |
| WO-2014002052-A1 | PYRROLIDINE DERIVATIVES AND THEIR USE AS COMPLEMENT PATHWAY MODULATORS | NOVARTIS AG (CH) | 2014-01-03 | — | — | WO | disclosed |